Our technology gives failed drug molecules a second chance.

Uncategorized

29.04.2019 Nanoform strengthens GMP capabilities with Head of Manufacturing appointment

PRESS RELEASE 29 April 2019 Nanoform strengthens GMP capabilities with Head of Manufacturing appointment Helsinki, Finland – Nanoform, an innovative drug enabling nanotechnology company, has appointed Dr David Rowe as its Head of Manufacturing. The new role will strengthen Nanoform’s manufacturing organization to efficiently deliver commercial APIs for global partners. Dr Rowe will be responsible …

29.04.2019 Nanoform strengthens GMP capabilities with Head of Manufacturing appointmentRead More »

02.04.2019 Nanoform strengthens board with appointment of Vice Chairman

PRESS RELEASE 2 April 2019 Nanoform strengthens board with appointment of Vice Chairman Helsinki, Finland – Nanoform, an innovative drug enabling nanotechnology company, has announced the appointment of Miguel Calado as Vice Chairman of the Board. His extensive expertise in strategic business management and finance will strengthen the board and drive Nanoform to further success …

02.04.2019 Nanoform strengthens board with appointment of Vice ChairmanRead More »

05.03.2019 Construction of Nanoform’s GMP manufacturing plant rapidly progresses

PRESS RELEASE 05 March 2019 Construction of Nanoform’s GMP manufacturing plant rapidly progresses Helsinki, Finland – Nanoform, an innovative drug enabling nanotechnology company, has announced significant progress in the construction of its new 600m2 GMP manufacturing plant, located at Cultivator II in Viikki Life Science Park, Finland. These important advancements in the project will enable …

05.03.2019 Construction of Nanoform’s GMP manufacturing plant rapidly progressesRead More »

07.01.2019 Nanoform significantly strengthens commercial organisation with Chief of Business Operations appointment

PRESS RELEASE 7 January 2019 Nanoform significantly strengthens commercial organisation with Chief of Business Operations appointment Helsinki, Finland – Nanoform, an innovative drug enabling nanotechnology company, has appointed Dr Gonçalo Rebelo de Andrade as Chief of Business Operations. The newly created role will significantly strengthen Nanoform’s commercial organisation and continue its rapid growth through international …

07.01.2019 Nanoform significantly strengthens commercial organisation with Chief of Business Operations appointmentRead More »